Based on solid-in-oil-in-water emulsification, we fabricated biodegradable poly(ϵ-caprolactone) microspheres containing gentamicin using conventional homogenization and a fluidic device. The feasibility of the poly(ϵ-caprolactone) microspheres as drug carriers was evaluated in terms of encapsulation efficiency, release behavior of gentamicin, and antimicrobial activity. The poly(ϵ-caprolactone) microspheres prepared using a fluidic device (fluidic device microspheres) had a uniform diameter and a smooth surface, whereas the poly(ϵ-caprolactone) microspheres prepared using conventional homogenization (conventional homogenization microspheres) exhibited polydisperse and a porous structure. At 0.3 wt% of gentamicin concentration, the encapsulation efficiencies of the conventional homogenization and fluidic device microspheres were 39.5% and 72.0%, respectively. In addition, a significant amount of gentamicin was only released initially from the conventional homogenization microspheres, whereas the fluidic device microspheres released gentamicin in a sustained manner for 28 days. These results confirmed the superior performances of the uniform fluidic device microspheres for drug delivery system. We further proposed a model for microsphere formation to explain the difference in performance of the conventional homogenization and fluidic device microspheres.
MotaCPuppiDDinucciD. Additive manufacturing of star poly(ϵ-caprolactone) wet-spun scaffolds for bone tissue engineering applications. J Bioact Compat Polym2013; 28: 320–340.
2.
RyuTKOhMGMoonSK. Uniform tricalcium phosphate beads with an open porous structure for tissue engineering. Colloids Surf B Biointerfaces2013; 112: 368–373.
3.
PaikDHJeongKYMoonSK. A facile method for preparation of polycaprolactone/tricalcium phosphate fibrous matrix with a gradient mineral content. Colloids Surf A Physicochem Eng Asp2013; 20: 134–141.
4.
RafieniaMOrangFEmamiSH. Preparation and characterization of polyurethane microspheres containing theophylline. J Bioact Compat Polym2006; 21: 341–349.
5.
ThatteSDatarKOttenbriteRM. Perspectives on: polymeric drugs and drug delivery systems. J Bioact Compat Polym2005; 20: 585–601.
6.
DernellWSWithrowSJKuntzCA. In vivo evaluation of gentamicin impregnated polylactic acid beads implanted in sheep. J Bioact Compat Polym2001; 16: 119–135.
7.
XuFYanTTLuoYL. Thermosensitive poly(N-isopropylacrylamide-co-N,N-dimethyl acryl amide)-block poly(D,L-lactide) amphiphilic block copolymer micelles for prednisone drug release. J Bioact Compat Polym2013; 28: 66–85.
8.
KimBYParkKMJoungYK. Preparation and characterizations of in situ shell cross-linked 4-arm-poly(propylene oxide)–poly(ethylene oxide) micelles via enzyme-mediated reaction for controlled drug delivery. J Bioact Compat Polym2012; 27: 185–197.
ChoYWChoiMLeeK. Cyclotriphosphazene-Pt-DACH conjugates with dipeptide spacers for drug delivery systems. J Bioact Compat Polym2010; 25: 274–291.
11.
ZhongMLChenXQFanHS. Incorporation of salmon calcitonin-loaded poly(lactide-co-glycolide) (PLGA) microspheres into calcium phosphate bone cement and the biocompatibility evaluation in vitro. J Bioact Compat Polym2012; 27: 133–147.
12.
HuSHLiaoBJChiangCS. Core-shell nanocapsules stabilized by single-component polymer and nanoparticles for magneto-chemotherapy hyperthermia with multiple drugs. Adv Mater2012; 24: 3627–3632.
13.
PanyamJWilliamsDDashA. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. J Pharm Sci2004; 93: 1804–1814.
14.
ChangHIPerrieYCoombesAG. Delivery of the antibiotic gentamicin sulphate from precipitation cast matrices of polycaprolactone. J Control Release2006; 110: 414–421.
15.
LecarozCGamazoCRenedoMJ. Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin. J Microencapsul2006; 23: 782–792.
16.
PriorSGamazoCIracheJM. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections. Int J Pharm2000; 196: 115–125.
17.
XiaZWangGTaoK. Preparation of magnetite–dextran microspheres by ultrasonication. J Magn Magn Mater2005; 293: 182–186.
18.
MaengYJChoiSWKimHO. Culture of human mesenchymal stem cells using electrosprayed porous chitosan microbeads. J Biomed Mater Res A2010; 92: 869–876.
19.
MeléndezRROuimetMAUhrichKE. Formulation of salicylate-based poly(anhydride-ester) microspheres for short- and long-term salicylic acid delivery. Polym Bull2013; 70: 343–351.
20.
ChoiSWZhangYXiaY. A temperature-sensitive drug release system based on phase change materials. Angew Chem Int Ed Engl2010; 49: 7904–7908.
21.
ChoiSWZhangYXiaY. Fabrication of microbeads with a controllable hollow interior and porous wall using a capillary fluidic device. Adv Funct Mater2009; 19: 2943–2949.
22.
XuQHashimotoMDangTT. Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery. Small2009; 5: 1575–1581.
23.
FrancisLMengDKnowlesJ. Controlled delivery of gentamicin using poly(3-hydroxybutyrate) microspheres. Int J Mol Sci2011; 12: 4294–4314.
24.
ChangHILauYCYanC. Controlled release of an antibiotic, gentamicin sulphate, from gravity spun polycaprolactone fibers. J Biomed Mater Res A2008; 84: 230–237.
25.
Checa-CasalenguaPJiangCBravo-OsunaI. Preservation of biological activity of glial cell line-derived neurotrophic factor (GDNF) after microencapsulation and sterilization by gamma irradiation. Int J Pharm2012; 436: 545–554.
26.
NandaHSKawazoeNZhangQ. Preparation of collagen porous scaffolds with controlled and sustained release of bioactive insulin. J Bioact Compat Polym2014; 29: 95–109.
27.
ChoiSWCheongIWKimJH. Preparation of uniform microspheres using a simple fluidic device and their crystallization into close-packed lattices. Small2009; 5: 454–459.
28.
SampathSSRobinsonDH. Comparison of new and existing spectrophotometric methods for the analysis of tobramycin and other amino glycosides. J Pharm Sci1990; 79: 428–431.
29.
StigterMBezemerJde GrootK. Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J Control Release2004; 99: 127–137.
30.
YuanWWuFGuoM. Development of protein delivery microsphere system by a novel S/O/O/W multi-emulsion. Eur J Pharm Sci2009; 36: 212–218.
31.
HuZLiuYYuanW. Effect of bases with different solubility on the release behavior of risperidone loaded PLGA microspheres. Colloids Surf B Biointerfaces2011; 86: 206–211.
32.
KohaneDSSmithSELouisDN. Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres. Pain2003; 104: 415–421.
33.
HeJFengMZhouX. Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer. Int J Pharm2011; 416: 69–76.
34.
HuangXBrazelCS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release2001; 73: 121–136.
